IO Biotech Stock Forecast

OTC-IOBTQ's stock price has decreased by -99.85% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts that cover IO Biotech stock have a consensus rating of "Sell" and an average price target of $0.43, which forecasts a 19,445.45% increase in the stock price over the next year. The lowest target is $0.36 and the highest is $0.50.

Price Target: $0.43 (+19,445.45%)

Analyst Consensus: Sell

Target	Low	Average	Median	High
Price	$0.36	$0.43	$0.50	$0.50
Change	+16263.6%	+19445.5%	+22627.3%	+22627.3%

* Price targets were last updated on Jan 23, 2026.

Analyst Ratings

The average analyst rating for IO Biotech stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	1	1	1	1	1	1
Buy	1	1	0	0	0	0
Hold	3	3	2	2	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	1	1	1	0
Total	5	5	4	4	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Allison Bratzel Piper Sandler	Piper Sandler	Hold Downgrades $3 → $0.5	Hold	Downgrades	$3 → $0.5	+22,627.27%	Jan 23, 2026
Michael Ulz Morgan Stanley	Morgan Stanley	Sell Downgrades $0.39 → $0.36	Sell	Downgrades	$0.39 → $0.36	+16,263.64%	Jan 8, 2026

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-1.30

from -1.45

EPS Next Year

-0.59

from -1.30

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025
Revenue	-	-	-	-	-	-
Operating Income	-10.15M	-41.23M	-71.42M	-91.44M	-95.18M	-83.00M
Net Income	-12.04M	-67.88M	-71.46M	-86.08M	-95.49M	-85.60M
EPS	-82.36	-17.30	-2.48	-1.98	-1.45	-1.30
Free Cash Flow	-6.09M	-25.08M	-33.50M	-42.19M	-49.31M	-69.00M
No. Analysts	-	-	-	-	-	1

Revenue Forecast

Revenue	2025	2026	2027
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-
Avg	-
Low	-

EPS Forecast

EPS	2025	2026	2027
High	-1.30
Avg	-1.30
Low	-1.30

EPS Growth

EPS Growth	2025	2026	2027
High	-
Avg	-
Low	-

Sources: Price targets and consensus ratings provided by TipRanks. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.